Evidence map›Paper›PMID 25526263›Full record

ArticlePloS one2014

Genome-wide SNP-genotyping array to study the evolution of the human pathogen Vibrio vulnificus biotype 3.

Nili Raz, Yael Danin-Poleg, Ryan B Hayman, Yudi Bar-On, Alex Linetsky, Michael Shmoish, Eva Sanjuán, Carmen Amaro, David R Walt, Yechezkel Kashi

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Phylogeny ofFrontiers in microbiology · 2017
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nili RazFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
Yael Danin-PolegFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
Ryan B HaymanDepartment of Chemistry, Tufts University, Medford, Massachusetts, United States of America.
Yudi Bar-OnFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
Alex LinetskyFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
Michael ShmoishBioinformatics Knowledge Unit, Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
Eva SanjuánDepartment of Microbiology, Faculty of Biology, University of Valencia, Valencia, Spain.
Carmen AmaroDepartment of Microbiology, Faculty of Biology, University of Valencia, Valencia, Spain.
David R WaltDepartment of Chemistry, Tufts University, Medford, Massachusetts, United States of America.
Yechezkel KashiFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vibrio vulnificus is an aquatic bacterium and an important human pathogen. Strains of V. vulnificus are classified into three different biotypes. The newly emerged biotype 3 has been found to be clonal and restricted to Israel. In the family Vibrionaceae, horizontal gene transfer is the main mechanism responsible for the emergence of new pathogen groups. To better understand the evolution of the bacterium, and in particular to trace the evolution of biotype 3, we performed genome-wide SNP genotyping of 254 clinical and environmental V. vulnificus isolates with worldwide distribution recovered over a 30-year period, representing all phylogeny groups. A custom single-nucleotide polymorphism (SNP) array implemented on the Illumina GoldenGate platform was developed based on 570 SNPs randomly distributed throughout the genome. In general, the genotyping results divided the V. vulnificus species into three main phylogenetic lineages and an additional subgroup, clade B, consisting of environmental and clinical isolates from Israel. Data analysis suggested that 69% of biotype 3 SNPs are similar to SNPs from clade B, indicating that biotype 3 and clade B have a common ancestor. The rest of the biotype 3 SNPs were scattered along the biotype 3 genome, probably representing multiple chromosomal segments that may have been horizontally inserted into the clade B recipient core genome from other phylogroups or bacterial species sharing the same ecological niche. Results emphasize the continuous evolution of V. vulnificus and support the emergence of new pathogenic groups within this species as a recurrent phenomenon. Our findings contribute to a broader understanding of the evolution of this human pathogen.

Indexed as

Evolution, MolecularGenome, ViralPolymorphism, Single NucleotideVibrio vulnificus

Identifiers

PMID25526263
PMCPMC4272304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.